GlassScriptPhysician profile
Callie D Montez
NPI 1932544723
$930.12
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.47 · 2020: $350 · 2021: $500 · 2022: $18.65.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $179.42 | 2020-2021 | |
| Lundbeck LLC | $113.08 | 2020-2021 | |
| Abbvie INC. | $96.41 | 2021 | |
| Eisai INC. | $92.56 | 2020-2021 | |
| Adlon Therapeutics L.P. | $92.14 | 2020-2021 | |
| Otsuka America Pharmaceutical, INC. | $66.18 | 2019-2021 | |
| Allergan, INC. | $58.60 | 2020 | |
| Sunovion Pharmaceuticals INC. | $53.38 | 2021 | |
| Ironshore Pharmaceuticals INC. | $45.95 | 2019-2020 | |
| Tris Pharma INC | $42.17 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $38.43 | 2021 | |
| Corium, LLC | $18.65 | 2022 | |
| Bausch Health US, LLC | $17.50 | 2021 | |
| Shire North American Group INC | $15.65 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Callie Montez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.